The post Just 4% Of Americans Believe Trump Claim About Tylenol appeared on BitcoinEthereumNews.com. Just 4% of Americans definitely believe – as President Donald Trump does – that taking Tylenol during pregnancy increases the risk of a child developing autism, a new KFF poll shows. In this photo, Trump, right, and Robert F. Kennedy Jr., US secretary of Health and Human Services (HHS), in the Roosevelt Room of the White House in Washington, DC, US, on Monday, Sept. 22, 2025. Trump said his administration was linking acetaminophen, the active ingredient in Tylenol, to autism and urging pregnant women to largely avoid the medication. Photographer: Francis Chung/Politico/Bloomberg © 2025 Bloomberg Finance LP Just 4% of Americans definitely believe – as President Donald Trump does – that taking Tylenol during pregnancy increases the risk of a child developing autism, a new KFF poll shows. The poll comes following last month’s warning by Trump and the White House’s top health official, U.S. Secretary of Health and Human Services Robert F. Kennedy Jr., that taking acetaminophen, which is the active ingredient in Tylenol, can increase the risk of autism. Though Trump and Kennedy blame Tylenol for putting children at risk for autism, science does not back up their claims. Their message of “don’t take Tylenol” has been rebuked by physicians, medical researchers and public health officials around the world. As one example, the European Medicines Agency emphasized that its recommendations had not changed. It considers acetaminophen a safe way to address pain and fever in pregnancy, which are conditions that “can be dangerous to developing babies if left untreated,” according to reports. And in the U.S., scores of medical groups have also affirmed the drug’s safety with the American College of Obstetricians and Gynecologists warning that “the conditions people use acetaminophen to treat during pregnancy are far more dangerous than any theoretical risks.” Thus, the KFF poll is… The post Just 4% Of Americans Believe Trump Claim About Tylenol appeared on BitcoinEthereumNews.com. Just 4% of Americans definitely believe – as President Donald Trump does – that taking Tylenol during pregnancy increases the risk of a child developing autism, a new KFF poll shows. In this photo, Trump, right, and Robert F. Kennedy Jr., US secretary of Health and Human Services (HHS), in the Roosevelt Room of the White House in Washington, DC, US, on Monday, Sept. 22, 2025. Trump said his administration was linking acetaminophen, the active ingredient in Tylenol, to autism and urging pregnant women to largely avoid the medication. Photographer: Francis Chung/Politico/Bloomberg © 2025 Bloomberg Finance LP Just 4% of Americans definitely believe – as President Donald Trump does – that taking Tylenol during pregnancy increases the risk of a child developing autism, a new KFF poll shows. The poll comes following last month’s warning by Trump and the White House’s top health official, U.S. Secretary of Health and Human Services Robert F. Kennedy Jr., that taking acetaminophen, which is the active ingredient in Tylenol, can increase the risk of autism. Though Trump and Kennedy blame Tylenol for putting children at risk for autism, science does not back up their claims. Their message of “don’t take Tylenol” has been rebuked by physicians, medical researchers and public health officials around the world. As one example, the European Medicines Agency emphasized that its recommendations had not changed. It considers acetaminophen a safe way to address pain and fever in pregnancy, which are conditions that “can be dangerous to developing babies if left untreated,” according to reports. And in the U.S., scores of medical groups have also affirmed the drug’s safety with the American College of Obstetricians and Gynecologists warning that “the conditions people use acetaminophen to treat during pregnancy are far more dangerous than any theoretical risks.” Thus, the KFF poll is…

Just 4% Of Americans Believe Trump Claim About Tylenol

Just 4% of Americans definitely believe – as President Donald Trump does – that taking Tylenol during pregnancy increases the risk of a child developing autism, a new KFF poll shows. In this photo, Trump, right, and Robert F. Kennedy Jr., US secretary of Health and Human Services (HHS), in the Roosevelt Room of the White House in Washington, DC, US, on Monday, Sept. 22, 2025. Trump said his administration was linking acetaminophen, the active ingredient in Tylenol, to autism and urging pregnant women to largely avoid the medication. Photographer: Francis Chung/Politico/Bloomberg

© 2025 Bloomberg Finance LP

Just 4% of Americans definitely believe – as President Donald Trump does – that taking Tylenol during pregnancy increases the risk of a child developing autism, a new KFF poll shows.

The poll comes following last month’s warning by Trump and the White House’s top health official, U.S. Secretary of Health and Human Services Robert F. Kennedy Jr., that taking acetaminophen, which is the active ingredient in Tylenol, can increase the risk of autism.

Though Trump and Kennedy blame Tylenol for putting children at risk for autism, science does not back up their claims. Their message of “don’t take Tylenol” has been rebuked by physicians, medical researchers and public health officials around the world.

As one example, the European Medicines Agency emphasized that its recommendations had not changed. It considers acetaminophen a safe way to address pain and fever in pregnancy, which are conditions that “can be dangerous to developing babies if left untreated,” according to reports. And in the U.S., scores of medical groups have also affirmed the drug’s safety with the American College of Obstetricians and Gynecologists warning that “the conditions people use acetaminophen to treat during pregnancy are far more dangerous than any theoretical risks.”

Thus, the KFF poll is good news for supporters of science. Very few, or just 4% of adults say the claim about a “causal relationship is definitely true,” KFF said in its poll analysis. Meanwhile, about one-third of the public, 35%, say the claim of a link between Tylenol and autism is “definitely false.”

But Trump’s claim has caused confusion. The KFF poll analysis says “most people are uncertain what to believe, with equal shares saying it is “probably true”and ‘probably false’ (30% in each case).”

Source: https://www.forbes.com/sites/brucejapsen/2025/10/09/just-4-of-americans-believe-trump-claim-about-tylenol/

Market Opportunity
4 Logo
4 Price(4)
$0.02117
$0.02117$0.02117
-3.24%
USD
4 (4) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Polymarket signals 98% chance Fed will keep rates steady in January meeting

Polymarket signals 98% chance Fed will keep rates steady in January meeting

The post Polymarket signals 98% chance Fed will keep rates steady in January meeting appeared on BitcoinEthereumNews.com. The US Federal Reserve is set to hold
Share
BitcoinEthereumNews2026/01/22 13:26
BlackRock boosts AI and US equity exposure in $185 billion models

BlackRock boosts AI and US equity exposure in $185 billion models

The post BlackRock boosts AI and US equity exposure in $185 billion models appeared on BitcoinEthereumNews.com. BlackRock is steering $185 billion worth of model portfolios deeper into US stocks and artificial intelligence. The decision came this week as the asset manager adjusted its entire model suite, increasing its equity allocation and dumping exposure to international developed markets. The firm now sits 2% overweight on stocks, after money moved between several of its biggest exchange-traded funds. This wasn’t a slow shuffle. Billions flowed across multiple ETFs on Tuesday as BlackRock executed the realignment. The iShares S&P 100 ETF (OEF) alone brought in $3.4 billion, the largest single-day haul in its history. The iShares Core S&P 500 ETF (IVV) collected $2.3 billion, while the iShares US Equity Factor Rotation Active ETF (DYNF) added nearly $2 billion. The rebalancing triggered swift inflows and outflows that realigned investor exposure on the back of performance data and macroeconomic outlooks. BlackRock raises equities on strong US earnings The model updates come as BlackRock backs the rally in American stocks, fueled by strong earnings and optimism around rate cuts. In an investment letter obtained by Bloomberg, the firm said US companies have delivered 11% earnings growth since the third quarter of 2024. Meanwhile, earnings across other developed markets barely touched 2%. That gap helped push the decision to drop international holdings in favor of American ones. Michael Gates, lead portfolio manager for BlackRock’s Target Allocation ETF model portfolio suite, said the US market is the only one showing consistency in sales growth, profit delivery, and revisions in analyst forecasts. “The US equity market continues to stand alone in terms of earnings delivery, sales growth and sustainable trends in analyst estimates and revisions,” Michael wrote. He added that non-US developed markets lagged far behind, especially when it came to sales. This week’s changes reflect that position. The move was made ahead of the Federal…
Share
BitcoinEthereumNews2025/09/18 01:44
Ripple CEO Forecasts Record Performance For Crypto In 2026

Ripple CEO Forecasts Record Performance For Crypto In 2026

The post Ripple CEO Forecasts Record Performance For Crypto In 2026 appeared on BitcoinEthereumNews.com. Ronaldo is an experienced crypto enthusiast dedicated to
Share
BitcoinEthereumNews2026/01/22 13:06